Smoking-Related Interstitial Lung Diseases

Clinics in Chest Medicine

Volumn 33, Issue 1, 2012, Pages 165-178

  Vassallo, Robert ^a,b   Ryu, Jay H ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Acute eosinophilic pneumonia; Desquamative interstitial pneumonia; Fibrosis; Interstitial lung disease; Pulmonary Langerhans cell histiocytosis; Respiratory bronchiolitis; Smoking

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOMODULATING AGENT; METHOTREXATE; PREDNISONE; VINBLASTINE;

BRONCHIOLE; BRONCHIOLITIS; CIGARETTE SMOKING; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FIBROSING ALVEOLITIS; HEREDITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTIOCYTOSIS; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG INFILTRATE; MICROSCOPY; PREVALENCE; PRIORITY JOURNAL; REMISSION; REVIEW; SMOKING CESSATION; THORAX RADIOGRAPHY;

ACUTE DISEASE; BRONCHIOLITIS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY EOSINOPHILIA; PULMONARY FIBROSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84857388048     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2011.11.004     Document Type: Review

References (127)

1. Fraig M., Shreesha U., Savici D., et al. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002, 26(5):647-653.
2. Friedman P.J., Liebow A.A., Sokoloff J. Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 1981, 60(6):385-396.
3. Ryu J.H., Colby T.V., Hartman T.E., et al. Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001, 17(1):122-132.
4. Ryu J.H., Myers J.L., Capizzi S.A., et al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 2005, 127(1):178-184.
5. Vassallo R., Ryu J.H., Schroeder D.R., et al. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 2002, 346(7):484-490.
6. Vassallo R., Jensen E.A., Colby T.V., et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003, 124(4):1199-1205.
7. Craig P.J., Wells A.U., Doffman S., et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004, 45(3):275-282.
8. Moon J., du Bois R.M., Colby T.V., et al. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999, 54(11):1009-1014.
9. Nakajima M., Matsushima T. Acute eosinophilic pneumonia following cigarette smoking. Intern Med 2000, 39(10):759-760.
10. Watanabe K., Fujimura M., Kasahara K., et al. Acute eosinophilic pneumonia following cigarette smoking: a case report including cigarette-smoking challenge test. Intern Med 2002, 41(11):1016-1020.
11. Donaghy M., Rees A.J. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 1983, 2(8364):1390-1393.
12. Nakajima M., Manabe T., Niki Y., et al. A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance. Chest 2000, 118(5):1517-1518.
13. Kitahara Y., Matsumoto K., Taooka Y., et al. Cigarette smoking-induced acute eosinophilic pneumonia showing tolerance in broncho-alveolar lavage findings. Intern Med 2003, 42(10):1016-1021.
14. Miyake Y., Sasaki S., Yokoyama T., et al. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan. Ann Occup Hyg 2005, 49(3):259-265.
15. Saag K.G., Kolluri S., Koehnke R.K., et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 1996, 39(10):1711-1719.
16. Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol 2000, 27(3):630-637.
17. Baumgartner K.B., Samet J.M., Stidley C.A., et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997, 155(1):242-248.
18. Luukkainen R., Saltyshev M., Pakkasela R., et al. Relationship of rheumatoid factor to lung diffusion capacity in smoking and non-smoking patients with rheumatoid arthritis. Scand J Rheumatol 1995, 24(2):119-120.
19. Valeyre D., Soler P., Clerici C., et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988, 43(7):516-524.
20. Hance A.J., Basset F., Saumon G., et al. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci 1986, 465:643-656.
21. Warren C.P. Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax 1977, 32(5):567-569.
22. Douglas J.G., Middleton W.G., Gaddie J., et al. Sarcoidosis: a disorder commoner in non-smokers?. Thorax 1986, 41(10):787-791.
23. Peros-Golubicic T., Ljubic S. Cigarette smoking and sarcoidosis. Acta Med Croatica 1995, 49(4-5):187-193.
24. Klareskog L., Stolt P., Lundberg K., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54(1):38-46.
25. Shorr A.F., Scoville S.L., Cersovsky S.B., et al. Acute eosinophilic pneumonia among US Military personnel deployed in or near Iraq. JAMA 2004, 292(24):2997-3005.
26. Girard M., Israel-Assayag E., Cormier Y. Pathogenesis of hypersensitivity pneumonitis. Curr Opin Allergy Clin Immunol 2004, 4(2):93-98.
27. Patel R.R., Ryu J.H., Vassallo R. Cigarette smoking and diffuse lung disease. Drugs 2008, 68(11):1511-1527.
28. Mogulkoc N., Veral A., Bishop P.W., et al. Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation. Chest 1999, 115(5):1452-1455.
29. Zeid N.A., Muller H.K. Tobacco smoke induced lung granulomas and tumors: association with pulmonary Langerhans cells. Pathology 1995, 27(3):247-254.
30. Negrin-Dastis S., Butenda D., Dorzee J., et al. Complete disappearance of lung abnormalities on high-resolution computed tomography: a case of histiocytosis X. Can Respir J 2007, 14(4):235-237.
31. Bernstrand C., Cederlund K., Ashtrom L., et al. Smoking preceded pulmonary involvement in adults with Langerhans cell histiocytosis diagnosed in childhood. Acta Paediatr 2000, 89(11):1389-1392.
32. Portnoy J., Veraldi K.L., Schwarz M.I., et al. Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest 2007, 131(3):664-671.
33. Etienne B., Bertocchi M., Gamondes J.P., et al. Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation. Am J Respir Crit Care Med 1998, 157(1):288-291.
34. Dauriat G., Mal H., Thabut G., et al. Lung transplantation for pulmonary Langerhans' cell histiocytosis: a multicenter analysis. Transplantation 2006, 81(5):746-750.
35. Shiota Y., Kawai T., Matsumoto H., et al. Acute eosinophilic pneumonia following cigarette smoking. Intern Med 2000, 39(10):830-833.
36. Alp H., Daum R.S., Abrahams C., et al. Acute eosinophilic pneumonia: a cause of reversible, severe, noninfectious respiratory failure. J Pediatr 1998, 132(3 Pt 1):540-543.
37. Nakagome K., Kato J., Kubota S., et al. Nihon Kokyuki Gakkai Zasshi 2000, 38(2):113-116. [in Japanese].
38. Katzenstein A.L., Mukhopadhyay S., Zanardi C., et al. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol 2010, 41(3):316-325.
39. Vassallo R., Tamada K., Lau J.S., et al. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 2005, 175(4):2684-2691.
40. Israel-Assayag E., Dakhama A., Lavigne S., et al. Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1999, 159(6):1830-1834.
41. Anderson K., Morrison S.M., Bourke S., et al. Effect of cigarette smoking on the specific antibody response in pigeon fanciers. Thorax 1988, 43(10):798-800.
42. Cormier Y., Belanger J., Durand P. Factors influencing the development of serum precipitins to farmer's lung antigen in Quebec dairy farmers. Thorax 1985, 40(2):138-142.
43. Hakala M., Paakko P., Huhti E., et al. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol 1990, 9(4):452-460.
44. Churg A., Muller N.L., Flint J., et al. Chronic hypersensitivity pneumonitis. Am J Surg Pathol 2006, 30(2):201-208.
45. Ranney L., Melvin C., Lux L., et al. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med 2006, 145(11):845-856.
46. Kuschner W.G., D'Alessandro A., Wong H., et al. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996, 9(10):1989-1994.
47. Casolaro M.A., Bernaudin J.F., Saltini C., et al. Accumulation of Langerhans' cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 1988, 137(2):406-411.
48. Colby T.V., Lombard C. Histiocytosis X in the lung. Hum Pathol 1983, 14(10):847-856.
49. Travis W.D., Borok Z., Roum J.H., et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol 1993, 17(10):971-986.
50. Myers J.L., Veal C.F., Shin M.S., et al. Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. Am Rev Respir Dis 1987, 135(4):880-884.
51. Remy-Jardin M., Remy J., Gosselin B., et al. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 1993, 186(3):643-651.
52. Tomita K., Caramori G., Lim S., et al. Increased p21(CIP1/WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers. Am J Respir Crit Care Med 2002, 166(5):724-731.
53. Tazi A., Bonay M., Bergeron A., et al. Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Thorax 1996, 51(6):611-614.
54. Tazi A., Bouchonnet F., Grandsaigne M., et al. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest 1993, 91(2):566-576.
55. Wang R.D., Wright J.L., Churg A. Transforming growth factor-beta1 drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol 2005, 33(4):387-393.
56. D'Hulst A.I., Vermaelen K.Y., Brusselle G.G., et al. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005, 26(2):204-213.
57. Lu L.M., Zavitz C.C., Chen B., et al. Cigarette smoke impairs NK cell-dependent tumor immune surveillance. J Immunol 2007, 178(2):936-943.
58. Kode A., Yang S.R., Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res 2006, 7:132.
59. Yang S.R., Chida A.S., Bauter M.R., et al. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006, 291(1):L46-L57.
60. Niewoehner D.E., Kleinerman J., Rice D.B. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974, 291(15):755-758.
61. Yousem S.A., Colby T.V., Gaensler E.A. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989, 64(11):1373-1380.
62. Mavridou D., Laws D. Respiratory bronchiolitis associated interstitial lung disease (RB-ILD): a case of an acute presentation. Thorax 2004, 59(10):910-911.
63. Hartman T.E., Tazelaar H.D., Swensen S.J., et al. Cigarette smoking: CT and pathologic findings of associated pulmonary diseases. Radiographics 1997, 17(2):377-390.
64. Aubry M.C., Wright J.L., Myers J.L. The pathology of smoking-related lung diseases. Clin Chest Med 2000, 21(1):11-35. vii.
65. Wells A.U., Nicholson A.G., Hansell D.M., et al. Respiratory bronchiolitis-associated interstitial lung disease. Semin Respir Crit Care Med 2003, 24(5):585-594.
66. Liebow A.A., Steer A., Billingsley J.G. Desquamative interstitial pneumonia. Am J Med 1965, 39:369-404.
67. Iskandar S.B., McKinney L.A., Shah L., et al. Desquamative interstitial pneumonia and hepatitis C virus infection: a rare association. South Med J 2004, 97(9):890-893.
68. Flores-Franco R.A., Luevano-Flores E., Gaston-Ramirez C. Sirolimus-associated desquamative interstitial pneumonia. Respiration 2007, 74(2):237-238.
69. Hansell D.M., Nicholson A.G. Smoking-related diffuse parenchymal lung disease: HRCT-pathologic correlation. Semin Respir Crit Care Med 2003, 24(4):377-392.
70. Heyneman L.E., Ward S., Lynch D.A., et al. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process?. AJR Am J Roentgenol 1999, 173(6):1617-1622.
71. Hartman T.E., Primack S.L., Kang E.Y., et al. Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT. Chest 1996, 110(2):378-382. [see comment].
72. Mueller-Mang C., Grosse C., Schmid K., et al. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics 2007, 27(3):595-615.
73. Matsuo K., Tada S., Kataoka M., et al. Spontaneous remission of desquamative interstitial pneumonia. Intern Med 1997, 36(10):728-731.
74. Bjoraker J.A., Ryu J.H., Edwin M.K., et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 157(1):199-203.
75. Flusser G., Gurman G., Zirkin H., et al. Desquamative interstitial pneumonitis causing acute respiratory failure, responsive only to immunosuppressants. Respiration 1991, 58(5-6):324-326.
76. Timmer S.J., Karamzadeh A.M., Yung G.L., et al. Predicting survival of lung transplantation candidates with idiopathic interstitial pneumonia: does PaO(2) predict survival?. Chest 2002, 122(3):779-784.
77. Verleden G.M., Sels F., Van Raemdonck D., et al. Possible recurrence of desquamative interstitial pneumonitis in a single lung transplant recipient. Eur Respir J 1998, 11(4):971-974.
78. Vassallo R., Ryu J.H., Colby T.V., et al. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 2000, 342(26):1969-1978.
79. Tazi A. Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J 2006, 27(6):1272-1285.
80. Favara B.E., Feller A.C., Pauli M., et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997, 29(3):157-166.
81. Chaowalit N., Pellikka P.A., Decker P.A., et al. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin Proc 2004, 79(10):1269-1275.
82. Delobbe A., Durieu J., Duhamel A., et al. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J 1996, 9(10):2002-2006.
83. Aguayo S.M., King T.E., Waldron J.A., et al. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest 1990, 86(3):838-844.
84. Asakura S., Colby T.V., Limper A.H. Tissue localization of transforming growth factor-beta1 in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med 1996, 154(5):1525-1530.
85. Mendez J.L., Nadrous H.F., Vassallo R., et al. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004, 125(3):1028-1032.
86. Crausman R.S., Jennings C.A., Tuder R.M., et al. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 1996, 153(1):426-435.
87. Moore A.D., Godwin J.D., Muller N.L., et al. Pulmonary histiocytosis X: comparison of radiographic and CT findings. Radiology 1989, 172(1):249-254.
88. Brauner M.W., Grenier P., Mouelhi M.M., et al. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989, 172(1):255-258.
89. Soler P., Chollet S., Jacque C., et al. Immunocytochemical characterization of pulmonary histiocytosis X cells in lung biopsies. Am J Pathol 1985, 118(3):439-451.
90. Chollet S., Soler P., Bernaudin J.F., et al. Presse Med 1984, 13(24):1503-1508. [in French].
91. Yousem S.A., Colby T.V., Chen Y.Y., et al. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001, 25(5):630-636.
92. Fartoukh M., Humbert M., Capron F., et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000, 161(1):216-223.
93. Abbott G.F., Rosado-de-Christenson M.L., Franks T.J., et al. From the archives of the AFIP: pulmonary Langerhans cell histiocytosis. Radiographics 2004, 24(3):821-841.
94. Aerni M.R., Aubry M.C., Myers J.L., et al. Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker. Respir Med 2008, 102(2):316-319.
95. Pardanani A., Phyliky R.L., Li C.Y., et al. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc 2003, 78(3):301-306.
96. Kiakouama L., Cottin V., Etienne-Mastroianni B., et al. Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan. Eur Respir J 2010, 36(1):202-204.
97. Saleem I., Moss J., Egan J.J. Lung transplantation for rare pulmonary diseases. Sarcoidosis Vasc Diffuse Lung Dis 2005, 22(Suppl 1):S85-S90.
98. Gabbay E., Dark J.H., Ashcroft T., et al. Recurrence of Langerhans' cell granulomatosis following lung transplantation. Thorax 1998, 53(4):326-327.
99. Philit F., Etienne-Mastroianni B., Parrot A., et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med 2002, 166(9):1235-1239.
100. Yokoyama A., Mizushima Y., Suzuki H., et al. Acute eosinophilic pneumonia induced by minocycline: prominent Kerley B lines as a feature of positive re-challenge test. Jpn J Med 1990, 29(2):195-198.
101. Barnes M.T., Bascunana J., Garcia B., et al. Acute eosinophilic pneumonia associated with antidepressant agents. Pharm World Sci 1999, 21(5):241-242.
102. Noh H., Lee Y.K., Kan S.W., et al. Acute eosinophilic pneumonia associated with amitriptyline in a hemodialysis patient. Yonsei Med J 2001, 42(3):357-359.
103. McCormick M., Nelson T. Cocaine-induced fatal acute eosinophilic pneumonia: a case report. WMJ 2007, 106(2):92-95.
104. Kawayama T., Fujiki R., Morimitsu Y., et al. Fatal idiopathic acute eosinophilic pneumonia with acute lung injury. Respirology 2002, 7(4):373-375.
105. Takizawa H. Acute eosinophilic pneumonia: possible role of hyperreactivity of airway epithelial cells. Intern Med 2002, 41(11):917.
106. Glazer C.S., Cohen L.B., Schwarz M.I. Acute eosinophilic pneumonia in AIDS. Chest 2001, 120(5):1732-1735.
107. Miki K., Miki M., Okano Y., et al. Cigarette smoke-induced acute eosinophilic pneumonia accompanied with neutrophilia in the blood. Intern Med 2002, 41(11):993-996.
108. Al-Saieg N., Moammar O., Kartan R. Flavored cigar smoking induces acute eosinophilic pneumonia. Chest 2007, 131(4):1234-1237.
109. Rom W.N., Weiden M., Garcia R., et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med 2002, 166(6):797-800.
110. Nakahara Y., Hayashi S., Fukuno Y., et al. Increased interleukin-5 levels in bronchoalveolar lavage fluid is a major factor for eosinophil accumulation in acute eosinophilic pneumonia. Respiration 2001, 68(4):389-395.
111. Daimon T., Johkoh T., Sumikawa H., et al. Acute eosinophilic pneumonia: thin-section CT findings in 29 patients. Eur J Radiol 2008, 65(3):462-467.
112. Allen J. Acute eosinophilic pneumonia. Semin Respir Crit Care Med 2006, 27(2):142-147.
113. King M.A., Pope-Harman A.L., Allen J.N., et al. Acute eosinophilic pneumonia: radiologic and clinical features. Radiology 1997, 203(3):715-719.
114. Allen J.N., Pacht E.R., Gadek J.E., et al. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989, 321(9):569-574.
115. Tazelaar H.D., Linz L.J., Colby T.V., et al. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med 1997, 155(1):296-302.
116. Uchiyama H., Suda T., Nakamura Y., et al. Alterations in smoking habits are associated with acute eosinophilic pneumonia. Chest 2008, 133(5):1174-1180.
117. Benz K., Amann K., Dittrich K., et al. Patient with antibody-negative relapse of Goodpasture syndrome. Clin Nephrol 2007, 67(4):240-244.
118. Antoniou K.M., Hansell D.M., Rubens M.B., et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 2008, 177(2):190-194.
119. King T.E., Tooze J.A., Schwarz M.I., et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001, 164(7):1171-1181.
120. Cottin V., Le Pavec J., Prevot G., et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010, 35(1):105-111.
121. Mejia M., Carrillo G., Rojas-Serrano J., et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009, 136(1):10-15.
122. Washko G.R., Hunninghake G.M., Fernandez I.E., et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011, 364(10):897-906.
123. King T.E. Smoking and subclinical interstitial lung disease. N Engl J Med 2011, 364(10):968-970.
124. Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med 2004, 25(3):531-547. vi.
125. Arima K., Ando M., Ito K., et al. Effect of cigarette smoking on prevalence of summer-type hypersensitivity pneumonitis caused by Trichosporon cutaneum. Arch Environ Health 1992, 47(4):274-278.
126. Ohtsuka Y., Munakata M., Tanimura K., et al. Smoking promotes insidious and chronic farmer's lung disease, and deteriorates the clinical outcome. Intern Med 1995, 34(10):966-971.
127. Newman L.S., Rose C.S., Bresnitz E.A., et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004, 170(12):1324-1330.